The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Value of 11C-methionine PET in imaging brain tumours and metastases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Chang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70263-3 · Cited by 2,475
Andrews, D. W., Scott, C. B., Sperduto, P. W., Flanders, A. E., Gaspar, L. E., Schell, M. C., Werner-Wasik, M., Demas, W., Ryu, J., Bahary, J.-P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16250-8 · Cited by 2,417
Barnholtz-Sloan, J. S., Sloan, A. E., Davis, F. G., Vigneau, F. D., Lai, P., & Sawaya, R. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.149 · Cited by 1,843
Walker, M. D., Alexander, E., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Mealey, J., Norrell, H. A., Owens, G., Ransohoff, J., Wilson, C. B., et al. (1978) · Journal of Neurosurgery · doi:10.3171/jns.1978.49.3.0333 · Cited by 1,667
Schouten, L. J., Rutten, J., Huveneers, H. A. M., & Twijnstra, A. (2002) · Cancer · doi:10.1002/cncr.10541 · Cited by 1,590
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
Sanai, N., & Berger, M. S. (2008) · Neurosurgery · doi:10.1227/01.neu.0000318159.21731.cf · Cited by 1,328
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., Tihan, T., VandenBerg, S., McDermott, M. W., & Berger, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9337 · Cited by 1,283
Ollinger, J. M., & Fessler, J. A. (1997) · IEEE Signal Processing Magazine · doi:10.1109/79.560323 · Cited by 1,167
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,121
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Brain metastases: epidemiology and pathophysiology
Gavrilovic, I. T., & Posner, J. B. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8093-6 · Cited by 975
Roa, W., Brasher, P. M. A., Bauman, G., Anthes, M., Bruera, E., Chan, A., Fisher, B., Fulton, D., Gulavita, S., Hao, C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.082 · Cited by 904
An analysis of dose-effect relationship in the radiotherapy of malignant gliomas
Walker, M. D., Strike, T. A., & Sheline, G. E. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90553-4 · Cited by 854
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Dijkers, E. C., Oude Munnink, T. H., Kosterink, J. G., Brouwers, A. H., Jager, P. L., de Jong, J. R., van Dongen, G. A., Schröder, C. P., Lub-de Hooge, M. N., & de Vries, E. G. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.12 · Cited by 805
Radiotherapy for Glioblastoma in the Elderly
Keime-Guibert, F., Chinot, O., Taillandier, L., Cartalat-Carel, S., Frenay, M., Kantor, G., Guillamo, J.-S., Jadaud, E., Colin, P., Bondiau, P.-Y., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065901 · Cited by 792
Distribution of Brain Metastases
Delattre, J. Y., Krol, G., Thaler, H. T., & Posner, J. B. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310047016 · Cited by 778
Yung, W. K. A., Prados, M. D., Yaya-Tur, R., Rosenfeld, S. S., Brada, M., Friedman, H. S., Albright, R., Olson, J., Chang, S. M., O'Neill, A. M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2762 · Cited by 761
Douw, L., Klein, M., Fagel, S. S., van den Heuvel, J., Taphoorn, M. J., Aaronson, N. K., Postma, T. J., Vandertop, W. P., Mooij, J. J., Boerman, R. H., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70204-2 · Cited by 757
Shaw, E., Arusell, R., Scheithauer, B., O’Fallon, J., O’Neill, B., Dinapoli, R., Nelson, D., Earle, J., Jones, C., Cascino, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.126 · Cited by 730
Cairncross, G., Berkey, B., Shaw, E., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L., Laperierre, N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3414 · Cited by 728
Identification of prognostic factors in patients with brain metastases: a review of 1292 patients
Lagerwaard, F., Levendag, P., Nowak, P. C. M., Eijkenboom, W. H., Hanssens, P. J., & Schmitz, P. M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00442-8 · Cited by 721
Karim, A. B. M. F., Maat, B., Hatlevoll, R., Menten, J., Rutten, E. H. J. M., Thomas, D. G. T., Mascarenhas, F., Horiot, J. C., Parvinen, L. M., van Reijn, M., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00352-5 · Cited by 694
van den Bent, M., Wefel, J., Schiff, D., Taphoorn, M., Jaeckle, K., Junck, L., Armstrong, T., Choucair, A., Waldman, A., Gorlia, T., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70057-2 · Cited by 645
Chang, C. H., Horton, J., Schoenfeld, D., Salazer, O., Perez-Tamayo, R., Kramer, S., Weinstein, A., Nelson, J. S., & Tsukada, Y. (1983) · Cancer · doi:10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2 · Cited by 598
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Jager, P. L., Vaalburg, W., Pruim, J., de Vries, E. G. E., Langen, K., & Piers, D. (2001) · PubMed · Cited by 558
Continuous growth of mean tumor diameter in a subset of grade II gliomas
Mandonnet, E., Delattre, J., Tanguy, M., Swanson, K. R., Carpentier, A. F., Duffau, H., Cornu, P., Van Effenterre, R., Alvord, E. C., & Capelle, L. (2003) · Annals of Neurology · doi:10.1002/ana.10528 · Cited by 493
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Wester, H. J., Herz, M., Weber, W., et al. (1999) · PubMed · Cited by 466
Kristiansen, K., Hagen, S., Kollevold, T., Torvik, A., Holme, I., Stat, M., Nesbakken, R., Hatlevoll, R., Lindgren, M., Brun, A., et al. (1981) · Cancer · doi:10.1002/1097-0142(19810215)47:4<649::aid-cncr2820470405>3.0.co;2-w · Cited by 424
Terakawa, Y., Tsuyuguchi, N., Iwai, Y., Yamanaka, K., Higashiyama, S., Takami, T., & Ohata, K. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048082 · Cited by 419
Limitations of stereotactic biopsy in the initial management of gliomas
Jackson, R. J., Fuller, G. N., Abi-Said, D., Lang, F. F., Gokaslan, Z. L., Shi, W. M., Wildrick, D. M., & Sawaya, R. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.3.193 · Cited by 416
Pseudoprogression and pseudoresponse in the treatment of gliomas
Brandsma, D., & van den Bent, M. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328332363e · Cited by 378
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Dhermain, F. G., Hau, P., Lanfermann, H., Jacobs, A. H., & van den Bent, M. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70181-2 · Cited by 368
Fogh, S. E., Andrews, D. W., Glass, J., Curran, W., Glass, C., Champ, C., Evans, J. J., Hyslop, T., Pequignot, E., Downes, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6941 · Cited by 347
Demographics of Brain Metastasis
Johnson, J. D., & Young, B. (1996) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30365-6 · Cited by 339
Kaschten, B., Stevenaert, A., Sadzot, B., Deprez, M., Degueldre, C., Fiore, G. D., Luxen, A., & Reznik, M. (1998) · PubMed · Cited by 327
van den Bent, M. J., Taphoorn, M. J. B., Brandes, A. A., Menten, J., Stupp, R., Frenay, M., Chinot, O., Kros, J. M., van der Rijt, C. C. D., Vecht, C. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.015 · Cited by 297
Delineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission Tomography
Kracht, L. W., Miletic, H., Busch, S., Jacobs, A. H., Voges, J., Hoevels, M., Klein, J. C., Herholz, K., & Heiss, W.-D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0262 · Cited by 292
Korshunov, A., Meyer, J., Capper, D., Christians, A., Remke, M., Witt, H., Pfister, S., von Deimling, A., & Hartmann, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0550-z · Cited by 279
Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine
Becherer, A., Karanikas, G., Szab�, M., Zettinig, G., Asenbaum, S., Marosi, C., Henk, C., Wunderbaldinger, P., Czech, T., Wadsak, W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1259-1 · Cited by 266
Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT
Boss, A., Bisdas, S., Kolb, A., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.074773 · Cited by 261
From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology
Kubota, K. (2001) · Annals of Nuclear Medicine · doi:10.1007/bf02988499 · Cited by 258
Grosu, A.-L., Astner, S. T., Riedel, E., Nieder, C., Wiedenmann, N., Heinemann, F., Schwaiger, M., Molls, M., Wester, H.-J., & Weber, W. A. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.07.002 · Cited by 253
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Hawkins, C., Walker, E., Mohamed, N., Zhang, C., Jacob, K., Shirinian, M., Alon, N., Kahn, D., Fried, I., Scheinemann, K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0034 · Cited by 250
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Pirotte, B. J. M., Goldman, S., Massager, N., David, P., Wikler, D., Vandesteene, A., Salmon, I. J., Brotchi, J., & Levivier, M. (2004) · PubMed · Cited by 248
Jacobs, A. H., Thomas, A., Kracht, L., Li, H., Dittmar, C., Garlip, G., Galldiks, N., Klein, J. C., Sobesky, J., Hilker, R., et al. (2005) · PubMed · Cited by 245
Grosu, A., Weber, W., Riedel, E., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.045 · Cited by 242
Sze, G. K., Milano, E., Johnson, C., & Heier, L. (1990) · PubMed Central · Cited by 240
11C-l-Methionine Positron Emission Tomography in the Clinical Management of Cerebral Gliomas
Singhal, T., Narayanan, T. K., Jain, V., Mukherjee, J., & Mantil, J. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0115-2 · Cited by 227
Changing Patterns of Bone and Brain Metastases in Patients with Colorectal Cancer
Sundermeyer, M. L., Meropol, N. J., Rogatko, A., Wang, H., & Cohen, S. J. (2005) · Clinical Colorectal Cancer · doi:10.3816/ccc.2005.n.022 · Cited by 216
Synthesis of L- and D-[methyl-11C]methionine.
Långström, B., Antoni, G., Gullberg, P., Halldin, C., Malmborg, P., Någren, K., Rimland, A., & Svärd, H. (1987) · PubMed · Cited by 216
Van Laere, K., Ceyssens, S., Van Calenbergh, F., de Groot, T., Menten, J., Flamen, P., Bormans, G., & Mortelmans, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1564-3 · Cited by 212
Kato, T., Shinoda, J., Nakayama, N., et al. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1008 · Cited by 199
Okubo, S., Zhen, H.-N., Kawai, N., Nishiyama, Y., Haba, R., & Tamiya, T. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0117-9 · Cited by 179
Management of Low-Grade Glioma
Pouratian, N., & Schiff, D. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0105-7 · Cited by 174
Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
Hartmann, C., Hentschel, B., Tatagiba, M., Schramm, J., Schnell, O., Seidel, C., Stein, R., Reifenberger, G., Pietsch, T., von Deimling, A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3194 · Cited by 171
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET
Kim, S., Chung, J.-K., Im, S.-H., Jeong, J. M., Lee, D. S., Kim, D. G., Jung, H., & Lee, M. C. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1598-6 · Cited by 168
PCV Chemotherapy for Recurrent Oligodendrogliomas and Oligoastrocytomas
Soffietti, R., Rudà, R., Bradac, G. B., & Schiffer, D. (1998) · Neurosurgery · doi:10.1097/00006123-199811000-00035 · Cited by 161
Kim, Y. H., Oh, S. W., Lim, Y. J., Park, C.-K., Lee, S.-H., Kang, K. W., Jung, H.-W., & Chang, K. H. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2010.06.005 · Cited by 158
Capillary ultrastructure in human metastatic brain tumors
Long, D. M. (1979) · Journal of Neurosurgery · doi:10.3171/jns.1979.51.1.0053 · Cited by 158
11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma
Hatakeyama, T., Kawai, N., Nishiyama, Y., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0847-5 · Cited by 157
Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients
Stark, A. M., van de Bergh, J., Hedderich, J., Mehdorn, H. M., & Nabavi, A. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.01.026 · Cited by 157
Goldman, S., Levivier, M., Pirotte, B. J. M., Brucher, J., Wikler, D., Damhaut, P., Dethy, S., Brotchi, J., & Hildebrand, J. G. (1997) · PubMed · Cited by 153
Lee, I. H., Piert, M., Gomez‐Hassan, D. M., Junck, L., Rogers, L. R., Hayman, J. A., Haken, R. K. T., Lawrence, T. S., Cao, Y., & Tsien, C. I. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.050 · Cited by 150
Therapeutic options for recurrent malignant glioma
Niyazi, M., Siefert, A., Schwarz, S. B., Ganswindt, U., Kreth, F.-W., Tonn, J., & Belka, C. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.11.006 · Cited by 150
Nuutinen, J., Sonninen, P. H., Lehikoinen, P., et al. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00604-0 · Cited by 149
Pirotte, B. J. M., Goldman, S., Dewitte, O., Massager, N., Wikler, D., Lefranc, F., Taib, N. O. B., Rorive, S., David, P., Brotchi, J., et al. (2006) · Journal of neurosurgery · doi:10.3171/jns.2006.104.2.238 · Cited by 140
Symptom response after palliative radiotherapy for patients with brain metastases
Bezjak, A., Adam, J., Barton, R., Panzarella, T., Laperrière, N., Wong, C. S., Mason, W. P., Buckley, C., Levin, W., McLean, M., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00150-2 · Cited by 134
Massager, N., David, P., Goldman, S., Pirotte, B. J. M., Wikler, D., Salmon, I. J., Nagy, N., Brotchi, J., & Levivier, M. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.6.0951 · Cited by 131
Quality of Life in Brain Metastases Radiation Trials: A Literature Review
Wong, J., Hird, A. E., Kirou-Mauro, A., Napolskikh, J., & Chow, E. (2008) · Current Oncology · doi:10.3747/co.v15i5.290 · Cited by 118
Whole brain radiotherapy for the treatment of multiple brain metastases
Tsao, M. N., Lloyd, N. S., Wong, R. K. S., Chow, E., Rakovitch, E., & Laperrière, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003869.pub2 · Cited by 116
Sato, N., Suzuki, M., Kuwata, N., Kuroda, K., Wada, T., Beppu, T., Sera, K., Sasaki, T., & Ogawa, A. (1999) · Neurosurgical Review · doi:10.1007/s101430050018 · Cited by 111
Molecular imaging of breast cancer
Munnink, T. H. O., Nagengast, W. B., Brouwers, A. H., Schröder, C. P., Hospers, G. A. P., Hooge, M. N. L.-D., van der Wall, E., van Diest, P. J., & de Vries, E. G. E. (2009) · The Breast · doi:10.1016/s0960-9776(09)70276-0 · Cited by 99
[11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.
Ceyssens, S. K., Laere, K. V., de Groot, T., Goffin, J., Bormans, G. M., & Mortelmans, L. (2006) · PubMed · Cited by 98
Gliomas With 1p/19q Codeletion:a.k.a. Oligodendroglioma
Cairncross, G. J., & Jenkins, R. B. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e31818d8178 · Cited by 96
Methyl-l-11C-Methionine PET as a Diagnostic Marker for Malignant Progression in Patients with Glioma
Ullrich, R. T., Kracht, L., Brunn, A., Herholz, K., Frommolt, P., Miletić, H., Deckert, M., Heiss, W., & Jacobs, A. H. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065904 · Cited by 94
Moulin-Romsee, G., D’Hondt, E., de Groot, T., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0557-4 · Cited by 91
PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?
Glaudemans, A. W. J. M., Quintero, A., & Signore, A. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2060-9 · Cited by 87
Self-citationSadeghi, N., Salmon, I. J., Decaestecker, C., Levivier, M., Metens, T., Wikler, D., Denolin, V., Rorive, S., Massager, N., Balériaux, D., et al. (2007) · PubMed Central · Cited by 86
Radionuclide imaging of bone marrow disorders
Agool, A., Glaudemans, A. W. J. M., Boersma, H. H., Dierckx, R., Vellenga, E., & Slart, R. H. J. A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1531-0 · Cited by 78
Self-citationStöber, B., Tanase, U., Herz, M., Seidl, C., Schwaiger, M., & Senekowitsch–Schmidtke, R. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0047-5 · Cited by 78
Addeo, R., Caraglia, M., Faiola, V., Capasso, E., Vincenzi, B., Montella, L., Guarrasi, R., Caserta, L., & Prete, S. D. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-18 · Cited by 76
11C-Acetate PET in the Evaluation of Brain Glioma: Comparison with 11C-Methionine and 18F-FDG-PET
Yamamoto, Y., Nishiyama, Y., Kimura, N., Kameyama, R., Kawai, N., Hatakeyama, T., Kaji, M., & Ohkawa, M. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0152-5 · Cited by 74
Taal, W., Dubbink, H. J., Zonnenberg, C. B. L., Zonnenberg, B. A., Postma, T. J., Gijtenbeek, J. M. M., Boogerd, W. J., Groenendijk, F. H., Kros, J. M., Kouwenhoven, M. C. M., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq177 · Cited by 74
Imaging of Cerebral Metastases
Schaefer, P. W., Budzik, R. F., & González, R. (1996) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30369-3 · Cited by 73
Galldiks, N., Kracht, L., Berthold, F., Miletić, H., Klein, J. C., Herholz, K., Jacobs, A. H., & Heiss, W. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9953-x · Cited by 68
Proliferation Markers for the Differential Diagnosis of Tumor and Inflammation
van Waarde, A., & Elsinga, P. H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549399 · Cited by 64
Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review
Pease, N. J., Edwards, A., & Moss, L. (2005) · Palliative Medicine · doi:10.1191/0269216305pm1017oa · Cited by 55
Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas
Smits, A., Westerberg, E., & Ribom, D. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0531-1 · Cited by 44
Spaeth, N., Wyss, M. T., Pahnke, J., Biollaz, G., Lutz, A. M., Goepfert, K., Westera, G., Treyer, V., Weber, B., & Buck, A. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0045-7 · Cited by 37
Hird, A. E., Wong, J., Zhang, L., Tsao, M. N., Barnes, E. A., Danjoux, C. E., & Chow, E. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0657-8 · Cited by 37
Biomarkers Classification and Therapeutic Decision-Making for Malignant Gliomas
Olar, A., & Aldape, K. (2012) · Current Treatment Options in Oncology · doi:10.1007/s11864-012-0210-8 · Cited by 30
Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas
Ribom, D., Schoenmaekers, M., Engler, H., et al. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-2031-5 · Cited by 29
Bevacizumab for the treatment of high-grade glioma
Khasraw, M., Simeonovic, M., & Grommes, C. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.694422 · Cited by 27
Nagata, T., Tsuyuguchi, N., Uda, T., Terakawa, Y., Takami, T., & Ohata, K. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.082875 · Cited by 14
Cited by
Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., la Fougère, C., Pope, W., Law, I., Arbizu, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now058 · Cited by 744
Methionine metabolism in health and cancer: a nexus of diet and precision medicine
Sanderson, S. M., Gao, X., Dai, Z., & Locasale, J. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0187-8 · Cited by 563
Chen, H., Pang, Y., Wu, J., Zhao, L., Hao, B., Wu, J., Wei, J., Wu, S., Zhao, L., Luo, Z., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04769-z · Cited by 545
Parkhitko, A. A., Jouandin, P., Mohr, S. E., & Perrimon, N. (2019) · Aging Cell · doi:10.1111/acel.13034 · Cited by 275
The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors
Pruis, I. J., van Dongen, G. A. M. S., & Veldhuijzen van Zanten, S. E. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031029 · Cited by 35
Metadata
- Authors
- Glaudemans, A. W. J. M., Enting, R. H., Heesters, M. A. A. M., Dierckx, R. A. J. O., van Rheenen, R. W. J., Walenkamp, A. M. E., & Slart, R. H. J. A.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2012-12-12
- Volume
- 40
- Issue
- 4
- Pages
- 615-635
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2467195988
- Cited by
- 286
- References
- 98
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.